Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

23 Dec 2020 Evaluate

Glenmark Pharmaceuticals has informed that the company has attached media release on 23rd December 2020, titled ‘Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray across numerous markets throughout Europe’ which is self explanatory.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..